Pages that link to "Q51000363"
Jump to navigation
Jump to search
The following pages link to Cognitive deterioration in patients with early multiple sclerosis: a 5-year study (Q51000363):
Displaying 27 items.
- Influence of corpus callosum damage on cognition and physical disability in multiple sclerosis: a multimodal study (Q21560983) (← links)
- Pharmacological treatment for memory disorder in multiple sclerosis (Q24201735) (← links)
- Optimizing the initial choice and timing of therapy in relapsing-remitting multiple sclerosis (Q26777686) (← links)
- Cognitive impairment in multiple sclerosis (Q28270988) (← links)
- Treatment of cognitive impairment in patients with multiple sclerosis (Q28272736) (← links)
- Subcutaneous interferon β-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study (Q31141962) (← links)
- Relationship between working hours and power of attention, memory, fatigue, depression and self-efficacy one year after diagnosis of clinically isolated syndrome and relapsing remitting multiple sclerosis (Q33553474) (← links)
- Low testosterone is associated with disability in men with multiple sclerosis (Q34302567) (← links)
- Impact of natalizumab treatment on fatigue, mood, and aspects of cognition in relapsing-remitting multiple sclerosis (Q35591351) (← links)
- Saffron ethanolic extract attenuates oxidative stress, spatial learning, and memory impairments induced by local injection of ethidium bromide (Q36209917) (← links)
- Limited health literacy and decline in executive function in older adults (Q37254414) (← links)
- Pediatric multiple sclerosis: current concepts and consensus definitions (Q37330502) (← links)
- Cognitive impairment among different clinical courses of multiple sclerosis (Q38449076) (← links)
- 'Hidden' factors influencing quality of life in patients with multiple sclerosis (Q38587673) (← links)
- Information processing speed in multiple sclerosis: Past, present, and future (Q38840386) (← links)
- Remotely Supervised Transcranial Direct Current Stimulation Increases the Benefit of At-Home Cognitive Training in Multiple Sclerosis (Q38948510) (← links)
- Randomized controlled trial of physical activity, cognition, and walking in multiple sclerosis. (Q45802723) (← links)
- Impact of anxiety on verbal and visuospatial working memory in patients with acute stroke without severe cognitive impairment. (Q47814374) (← links)
- The effects of long-term interferon-beta-1b treatment on cognitive functioning in multiple sclerosis: a 16-year longitudinal study (Q48477314) (← links)
- Repeated Assessment and Practice Effects of the Written Symbol Digit Modalities Test Using a Short Inter-Test Interval (Q48668774) (← links)
- Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome (Q48704199) (← links)
- Alemtuzumab Improves Cognitive Processing Speed in Active Multiple Sclerosis-A Longitudinal Observational Study (Q49539768) (← links)
- Ocular motor measures of cognitive dysfunction in multiple sclerosis II: working memory. (Q50592731) (← links)
- Retinal measures correlate with cognitive and physical disability in early multiple sclerosis (Q50593721) (← links)
- Distinctive Pattern of Cognitive Disorders During Multiple Sclerosis Relapse and Recovery Based on Computerized CANTAB Tests. (Q64906933) (← links)
- A longitudinal study of cognitive function in multiple sclerosis: is decline inevitable? (Q89485549) (← links)
- A Pilot Study to Assess At-Home Speed of Processing Training for Individuals with Multiple Sclerosis (Q91642381) (← links)